Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion type Assertion NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_head.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_provenance.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion evidence source_evidence_literature NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_provenance.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion SIO_000772 20623637 NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_provenance.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion wasDerivedFrom befree-20150227 NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_provenance.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion wasGeneratedBy ECO_0000203 NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_provenance.